Price Chart
Key Statistics
Previous Close
$30.85Day Range
52-Week Range
Avg Volume
24.4KDividend Yield
1.27%Expense Ratio
0.59%AUM
$46.9MShares Outstanding
1.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 50.73% |
| Denmark | 18.91% |
| China | 10.89% |
| Japan | 5.39% |
| South Korea | 4.34% |
| United Kingdom | 3.29% |
| Switzerland | 2.83% |
| Hong Kong | 2.53% |
| Singapore | 0.72% |
| Other | 0.35% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $46.9M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 66.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 19.50% | 8,507 | $9.9M |
| 2 | NVO | Novo Nordisk A/S | 12.93% | 149,003 | $6.6M |
| 3 | PFE | Pfizer Inc | 6.53% | 126,474 | $3.3M |
| 4 | 1093.HK | CSPC Pharmaceutical Group Ltd | 4.41% | 2,430,000 | $2.2M |
| 5 | VKTX | Viking Therapeutics Inc | 4.28% | 75,861 | $2.2M |
| 6 | 4519.T | Chugai Pharmaceutical Co Ltd | 4.07% | 44,600 | $2.1M |
| 7 | KLRA | Kailera Therapeutics Inc | 3.86% | 100,047 | $2.0M |
| 8 | AMGN | Amgen Inc | 3.80% | 5,434 | $1.9M |
| 9 | ZEAL.CO | Zealand Pharma A/S | 3.78% | 42,239 | $1.9M |
| 10 | 1801.HK | Innovent Biologics Inc | 3.56% | 193,500 | $1.8M |
| 11 | 128940.KS | Hanmi Pharm Co Ltd | 3.37% | 6,360 | $1.7M |
| 12 | AZN | AstraZeneca PLC | 3.30% | 9,158 | $1.7M |
| 13 | GPCR | Structure Therapeutics Inc | 2.89% | 33,754 | $1.5M |
| 14 | ROP.SW | Roche Holding AG | 2.82% | 3,518 | $1.4M |
| 15 | REGN | Regeneron Pharmaceuticals Inc | 2.49% | 2,061 | $1.3M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.89% | |
| 1W | +2.58% | |
| 1M | -0.94% | |
| 3M | -3.66% | |
| 6M | -10.24% | |
| YTD | -11.00% | |
| 1Y | +15.10% | |
| 3Y | +20.46% | |
| 5Y | +20.46% |
Moving Averages
$30.69
Below 20-Day MA$31.19
Below 50-Day MA$31.20
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$30.58
52-Week Low
$23.47
Current Yield
1.27%
Annual Dividend
$0.4630
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(176 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.61% | 0.66% |
| AUM | $46.9M | $910.0M | $1.47B |
| Dividend Yield | 1.27% | 3.35% | 1.82% |
| Avg Volume | 24.4K | 275.1K | 513.7K |
| Holdings | 29 | 99 | 42 |
| Performance | |||
| 1-Month Return | -3.95% | +1.77% | +1.84% |
| 6-Month Return | -10.75% | +3.26% | +4.31% |
| YTD Return | -10.53% | +3.61% | +4.82% |
| 1-Year Return | +12.27% | +24.59% | +35.88% |
Compare with Another ETF
Search for an ETF to compare with OZEM:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.